Catalyst Pharmaceuticals, Inc. (CPRX) Financials
CPRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 471.9 million | 84.0 million |
2023-09-30 | 413.2 million | 64.7 million |
2023-06-30 | 443.9 million | 68.6 million |
2023-03-31 | 407.2 million | 73.6 million |
CPRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 19.6 million | 4.3 million |
2023-09-30 | -34.2 million | 3.8 million |
2023-06-30 | 30.8 million | 3.3 million |
2023-03-31 | 12.0 million | 2.9 million |
CPRX Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 34.8 million |
2023-09-30 | -30.8 million |
2023-06-30 | 37.8 million |
2023-03-31 | 29.6 million |
CPRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 137.6 million | - | 3.6 million |
2023-09-30 | 121.0 million | - | 3.6 million |
2023-06-30 | 178.8 million | - | 3.7 million |
2023-03-31 | 148.2 million | - | 3.5 million |
CPRX Shares Outstanding
CPRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 36.1 million | 2.0 million | 13.1 million | 28.9 million |
2023-09-30 | 79.4 million | 83.7 million | 11.9 million | 21.7 million |
2023-06-30 | - | 4.0 million | 10.1 million | 18.3 million |
2023-03-31 | 74000 | 3.6 million | 12.0 million | 17.8 million |
CPRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 110.6 million | 24.9 million |
2023-09-30 | 102.7 million | 14.2 million |
2023-06-30 | 99.6 million | 12.0 million |
2023-03-31 | 85.4 million | 9.9 million |
CPRX
Price: $14.72
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.63 USD
P/E Ratio: 25.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -4.3 millionMarket Capitalization: 1.8 billion